Stock & Company Details
Genelux Corp $GNLX
Price:
N/A
N/A
45M
$109M
52 Week High:
N/A
10 Day Average Volume:
N/A
-2.63
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
GNLX technical indicators
Latest Genelux Corp (GNLX) indicator readings as of 2026-11-19.
GNLX's 14-day RSI is 57.2, in neutral territory. ADX reads 16.6, indicating a range-bound market rather than a trend. MACD (12, 26, 9) is -0.06, below the zero line.
Overview
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec) and others.
Finance Bot
Ask your questions
Start by typing a question below.